A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Epithelial Ovarian Carcinoma Patients

By Homesley H.   Benigno B.   Williams J.   Vaccarello L.  

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 171-177

Academic Press

Access to resources Recommend Favorite

A Dose-Escalating Study of Weekly Bolus Topotecan in Previously Treated Ovarian Cancer Patients

By Homesley H.D.   Hall D.J.   Martin D.A.   Lewandowski G.S.   Vaccarello L.   Nahhas W.A.   Suggs C.L.   Penley R.G.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 394-399

Elsevier

Access to resources Recommend Favorite

Effect of topotecan infusion duration on hematologic toxicity in recurrent ovarian carcinoma

By Puls Larry   Hunter James   Crane Martin  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 25-33

Humana Press, Inc

Access to resources Recommend Favorite

A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy

By Chua D.T.T.   Kwong D.L.W.   Sham J.S.T.   Au G.K.H.   Choy D.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 736-741

Elsevier

Access to resources Recommend Favorite

Adenovirus-Mediated Thymidine Kinase Gene Therapy in Combination with Topotecan for Patients with Recurrent Ovarian Cancer: 2.5-Year Follow-Up

By Hasenburg A.   Tong X.-W.   Fischer P.D.   Rojas-Martinez A.   Nyberg-Hoffman C.   Kaplan A.L.   Kaufman R.H.   Ramzy I.   Aguilar-Cordova E.   Kieback D.G.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 549-554

Elsevier

Access to resources Recommend Favorite